PKO Investment Management Joint-Stock’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.5M Sell
8,750
-1,350
-13% -$1.38M 0.76% 32
2026
Q1
$9.29M Buy
10,100
+100
+1% +$101K 0.78% 31
2025
Q4
$10.7M Sell
10,000
-3,926
-28% -$3.75M 0.86% 25
2025
Q3
$10.6M Sell
13,926
-500
-3% -$372K 0.91% 23
2025
Q2
$11.2M Buy
14,426
+4,826
+50% +$3.75M 1.21% 20
2025
Q1
$7.93M Buy
9,600
+2,100
+28% +$1.75M 0.9% 23
2024
Q4
$5.79M Buy
7,500
+300
+4% +$248K 0.72% 29
2024
Q3
$6.38M Sell
7,200
-1,620
-18% -$1.46M 0.79% 19
2024
Q2
$7.99M Buy
8,820
+2,020
+30% +$1.62M 0.99% 18
2024
Q1
$5.32M Buy
6,800
+300
+5% +$214K 0.63% 24
2023
Q4
$3.79M Hold
6,500
0.47% 34
2023
Q3
$3.49M Hold
6,500
0.47% 34
2023
Q2
$3.05M Sell
6,500
-2,700
-29% -$1.13M 0.37% 49
2023
Q1
$3.16M Buy
9,200
+1,700
+23% +$573K 0.42% 45
2022
Q4
$2.74M Sell
7,500
-1,000
-12% -$355K 0.4% 50
2022
Q3
$2.75M Buy
8,500
+500
+6% +$158K 0.47% 46
2022
Q2
$2.59M Sell
8,000
-500
-6% -$150K 0.37% 60
2022
Q1
$2.43M Sell
8,500
-15,477
-65% -$3.98M 0.29% 67
2021
Q4
$6.62M Sell
23,977
-10,098
-30% -$2.56M 0.75% 37
2021
Q3
$7.87M Buy
34,075
+8,979
+36% +$2.22M 0.94% 31
2021
Q2
$5.76M Buy
+25,096
New +$5.04M 0.72% 38

Other funds holding LLY

PKO Investment Management Joint-Stock's LLY Position: Q2 2026 in Review

PKO Investment Management Joint-Stock reduced its Eli Lilly (LLY) stake by 13% in Q2 2026, selling an estimated $1.38M and leaving 8,750 shares worth $10.5M. The position accounts for 0.76% of the portfolio, ranked #32.

PKO Investment Management Joint-Stock first reported a position in LLY in Q2 2021 and has held it in 21 quarters since. The position peaked at $11.2M in Q2 2025. 1,844 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • PKO Investment Management Joint-Stock held 8,750 shares of Eli Lilly worth $10.5M as of Q2 2026.
  • PKO Investment Management Joint-Stock sold 1,350 Eli Lilly shares in Q2 2026, an estimated $1.38M.
  • Eli Lilly made up 0.76% of PKO Investment Management Joint-Stock's portfolio in Q2 2026, its #32 holding.
  • PKO Investment Management Joint-Stock first reported a position in Eli Lilly in Q2 2021 and has held it in 21 quarters since.
  • PKO Investment Management Joint-Stock's Eli Lilly position peaked at $11.2M in Q2 2025.
  • 1,844 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on PKO Investment Management Joint-Stock's 13F filing for Q2 2026, filed 20 Jul 2026.